A shadow market for unlicensed weight-loss drugs is being driven by TikTok fitness influencers and sellers on messaging platforms, according to new investigations.
Investigational Drug Acquiring Traction Via Social Media
Retatrutide, which is still in research studies, is being advertised by social media influencers for its alleged weight-reducing properties. Followers are urged to message these profiles privately for source information, while also obtaining promotional offers.
Active Commerce on Messaging Platforms
Additionally, a robust market exists on Telegram, where groups with thousands of members share “before and after” photos, administration instructions and claims of rapid British shipping. Sellers market the substance there before redirecting customers to other platforms for purchases.
Learning About The Experimental Drug
Retatrutide is an investigational injection created by US drugmaker Eli Lilly. The drug targets three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies indicate it could help individuals reduce up to a quarter of their total weight. Nicknamed the “triple G”, the drug is being hailed digitally as the next Ozempic.
Healthcare Experts Express Worries
Nevertheless, physicians and pharmacists have warned that the distribution of what remains an unapproved drug in the UK is worrisome and could result in users injecting substances of unknown origin.
Some professionals stated the popularity for the experimental drug could be linked to the rising price of approved weight loss treatments such as Mounjaro.
Regulatory Position and Enforcement
Selling the unapproved drug on social media or Telegram is illegal in the United Kingdom, as it is an unapproved medication that must not be marketed or supplied for human use under the British medical regulations.
Several influencers try to circumvent the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled substance, but advertising and distribution can still violate medicines, advertising, and customer regulations, risking penalties, legal action or prison.
Service Reaction and Content Removal
According to TikTok, the platform has taken down violative content and banned related keywords and query recommendations. The company said it was committed to keeping the platform safe and investing in strengthening enforcement strategies.
Online Trading Activities
Research also found groups with up to 9,000 members selling the experimental drug using the platform's built-in discovery tool, which operates like a online catalog. Typing “retatrutide” instantly brings up channels with thousands of members, populated with photos of weight loss, positive testimonials and step-by-step instructions for mixing or injecting at residence.
Within moments of joining one group, a vendor posted WhatsApp details, where most purchases occur. The seller sent an guidebook and guaranteed delivery within two days. When asked whether the product was authentic, one seller responded: “You can’t be sure.” Another provided a photo of a supposed laboratory certificate. None asked about weight, health issues or previous experience.
Product Details and Costs
Within these communities, posts show dark colored packages with postal service labels, claiming to contain new batches. One message stated: “It took eight of us to load them this morning.”
Buyers can select between powder vials, mixed at residence with sterile water, or ready-to-use pens typically sold at 160 pounds for 20mg. When questioned how long a injector should be used, sellers give contradictory responses varying between a few weeks to “depends on your body”.
Service Oversight and Safety Measures
A spokesperson for Telegram stated it actively monitored dangerous content on its service including content that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.
Healthcare Expert Warnings
“Individuals are injecting substances they cannot confirm. Although the research behind retatrutide is sound, these online products may not include what they claim,” said a pharmacy expert, the director of pharmacy at Chemist4U.
A medical professional of an online medical service connected the surge in demand to current cost increases for authorized slimming drugs such as Mounjaro. “With costs increasing, individuals are turning to online platforms. But fake treatments are highly dangerous. You can’t be certain what’s inside or whether the environment they were produced in was sterile,” she said.
Her staff has previously seen individuals harmed by self-injection from unverified sources. “We recognize the disappointment, but purchasing from Telegram or WhatsApp is gambling with your well-being,” said the doctor. “These materials could be impure or incorrectly dosed.”
Manufacturer Statement
A representative from Eli Lilly said retatrutide was in phase 3 clinical trials and had not been reviewed or authorized by any regulatory agency anywhere in the world. “Therefore at this time no one can market [it] for personal consumption,” they said, noting that any item “misleadingly claiming itself as a Lilly experimental substance not yet authorized … may subject patients to potentially serious medical dangers”.
